Medical
Leading cause of diabetes hospitalisations targeted in bold research
Medical: On World Diabetes Day, Diabetes Australia Group CEO Justine Cain emphasised the pivotal role of research in transforming the […]
MoreMedical
Medical research misconduct rocks Australian institutions, sparks calls for overhaul
Medical: The alarm has been raised on the nation’s research sector, emphasising the need for an independent research integrity watchdog. […]
MoreMedical
Scientific leaders issue a compelling call to double investment in research
Medical: The nation’s science and technology sectors are seeking robust commitments from political parties and candidates ahead of the federal […]
MoreMedical
Privacy vs. progress: Government’s move in medical research consent
In a delicate balancing act, the Australian government has addressed the growing tension between the public’s demand for medical advancements […]
MoreMedical
Critical concerns emerge as Australia’s research priorities consultation takes centre stage
Australia’s scientific landscape is undergoing a significant transformation with the revival of the National Science and Research Priorities and the […]
MoreMedical
New report exposes critical gaps in clinical research and funding
Medical: The Department of Health and Aged Care has unveiled the long-awaited report detailing the evaluation of the Medical Research […]
MoreMedical
Leading the next chapter of medical affairs: New Interim President, Lauren Pasfield
Medical: In this podcast, Lauren Pasfield, Senior Medical Manager at AbbVie shared valuable insights into her new role as the […]
MoreMedical
Australia’s alarming slide: Declining investment in R&D sparks fierce debate
Medical: In a release that is raising eyebrows across the nation, Australia’s investment in science and research and development (R&D) […]
MoreMedical
Medical Affairs association welcomes AbbVie leader as interim President, charting the path ahead
Medical: In a significant development for the Medical Affairs Professionals of Australasia (MAPA), the current MAPA President, Matt Britland, has […]
MoreMedical
Unmasking the complex realities of Australia’s clinical trials
Medical: A deep dive into Australia’s clinical trials evolution across 15 years has unearthed vital insights into the challenges and […]
MoreRecent Posts in Pharma, MedTech & Biotech
Government’s long-awaited response to The New Frontier report unveiled after two-year wait
December 1, 2023
in News & Trends - Pharmaceuticals
Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’
December 1, 2023
in News & Trends - Pharmaceuticals
AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years
December 1, 2023
in News & Trends - Pharmaceuticals
New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding
November 30, 2023
in ESG
National Reconstruction Fund is ‘open for business’
November 30, 2023
in News & Trends - MedTech & Diagnostics
‘Overpriced medical devices are a key factor in driving higher premiums’, says Private Healthcare Australia amid escalating management expenses
November 30, 2023
in News & Trends - MedTech & Diagnostics
Dermatologists raise concerns over safety, care fragmentation and conflict of interest in pharmacy pilot expansion
November 30, 2023
in News & Trends - Pharmaceuticals
ResMed issues safety warning, one year after competitor alert
November 30, 2023
in News & Trends - MedTech & Diagnostics
Follow Us
Partner with us
News & Trends - Pharmaceuticals
Government’s long-awaited response to The New Frontier report unveiled after two-year wait
Pharma News: The Albanese Government has tabled its response to the House of Reps inquiry and The New Frontier report […]
MoreNews & Trends - Pharmaceuticals
Gilead welcomes HIV Taskforce report and celebrates the ‘unsung heroes’
Pharma News: On World AIDS Day, the National Association of People with HIV Australia (NAPWHA) and Gilead Sciences Australia have […]
MoreNews & Trends - Pharmaceuticals
AbbVie secures PBS listing of first therapy for Crohn’s disease in seven years
Pharma News: AbbVie’s Rinvoq (upadacitinib), a once-daily tablet, has been officially listed on the Pharmaceutical Benefits Scheme (PBS) for adult […]
MoreESG
New report calls on policy integration of sustainability in medical device and pharmaceutical registrations and funding
ESG: Increasing pressures from diverse stakeholder groups, spanning policymakers, investors, customers, and employees, have elevated Environmental, Social, and Governance (ESG) […]
More